Recently, the importance of the neurovascular unit, which is comprised of neurons, endothelial cells and astrocytes, has received great attention in the field of stroke, because stroke affects not only neurons, but also astrocytes and microvessels. Within the neurovascular unit, endothelial cells are critical for maintaining normal hemodynamic and metabolic homeostasis. Vascular damage during ischemia often leads to the disruption of the blood-brain barrier and dysregulation of vascular tonus, eventually causing substantial cell death. The Chinese herbs Rhodiolase, Notoginseng, Folium Ginkgo and Rhizoma Chuanxiong have been used for stroke ancillary treatment in China for years. Braintone contains four major active ingredients: Radix Rhodiolase Essence (a major constituent of Rhodiola rosea L.), Radix Notoginseng Essence, Folium Ginkgo Essence and Rhizoma Chuanxiong. A recent study published in the Neural Regeneration Research (Vol. 8, No. 19, 2013) combined novel in vivo and in vitro experiments to show that Braintone dose-dependently increased the expression of hypoxia inducible factor 1α, heme oxygenase-1 and vascular endothelial growth factor in the ischemic cortex of rats with middle cerebral artery occlusion. Braintone-containing serum increased levels of hypoxia-inducible factor 1α mRNA and protein, and elevated vascular endothelial growth factor mRNA and heme oxygenase-1 protein expression in a dose-dependent manner in human umbilical vein endothelial cells after glucose-oxygen deprivation. Collectively, these experimental findings suggest that Braintone has neuroprotective effects on ischemia-induced brain damage via the up-regulation of hypoxia-inducible factor 1α, heme oxygenase-1 and vascular endothelial growth factor expression in vascular endothelial cells.
Article: " Evidence for a therapeutic effect of Braintone on ischemic brain damage " by Yuanyuan Qin1, 2, Yu Luo1, Weiwei Gu1, Lei Yang1, Xikun Shen2, Zhenlun Gu1, Huiling Zhang1, Xiumei Gao3 (1 Department of Pharmacology and Laboratory of Cerebrovascular Pharmacology, College of Pharmaceutical Science, Suzhou Institute of Chinese Meteria Medica, Soochow University, Suzhou 215123, Jiangsu Province, China; 2 Department of Pharmacy, Suzhou Hospital of Traditional Chinese Medicine, Suzhou 215009, Jiangsu Province, China; 3 Department of Anesthesiology, Daxing Hospital, Capital University of Medical Sciences, Beijing 102600, China)
Qin YY, Luo Y, Gu WW, Yang L, Shen XK, Gu ZL, Zhang HL, Gao XM. Evidence for a therapeutic effect of Braintone on ischemic brain damage. Neural Regen Res. 2013;8(19):1743-1755.
Contact: Meng Zhao
Neural Regeneration Research
Full text: http://www.sjzsyj.org:8080/Jweb_sjzs/CN/article/downloadArticleFile.do?attachType=PDF&id=645
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.